Ampudia-Blasco FJ - Search Results

1

Real-World Evaluation of GLP-1 Receptor Agonist Therapy Persistence, Adherence and Therapeutic Inertia Among Obese Adults with Type 2 Diabetes.

Palanca A, Ampudia-Blasco FJ, Calderón JM, Sauri I, Martinez-Hervás S, Trillo JL, Redón J, Real JT. Palanca A, et al. Among authors: ampudia blasco fj. Diabetes Ther. 2023 Apr;14(4):723-736. doi: 10.1007/s13300-023-01382-9. Epub 2023 Feb 27. Diabetes Ther. 2023. PMID: 36847952 Free PMC article.

2

Therapeutic inertia in patients with type 2 diabetes treated with non-insulin agents.

Ampudia-Blasco FJ, Palanca A, Trillo JL, Navarro J, Real JT. Ampudia-Blasco FJ, et al. J Diabetes Complications. 2021 Mar;35(3):107828. doi: 10.1016/j.jdiacomp.2020.107828. Epub 2021 Jan 5. J Diabetes Complications. 2021. PMID: 33436143

3

Real-world Evidence of Efficacy and Safety of SGLT2 Inhibitors as Adjunctive Therapy in Adults With Type 1 Diabetes: A European Two-Center Experience.

Palanca A, van Nes F, Pardo F, Ampudia Blasco FJ, Mathieu C. Palanca A, et al. Diabetes Care. 2022 Mar 1;45(3):650-658. doi: 10.2337/dc21-1584. Diabetes Care. 2022. PMID: 35061022

4

Impact of COVID-19 lockdown on diabetes management and follow-up in a broad population in Spain.

Palanca A, Quinones-Torrelo C, Girbés J, Real JT, Ampudia-Blasco FJ. Palanca A, et al. Eur J Clin Invest. 2022 Jun;52(6):e13771. doi: 10.1111/eci.13771. Epub 2022 Mar 27. Eur J Clin Invest. 2022. PMID: 35313009 Free PMC article.

5

The Controversial Role of Vitamin D in Thyroid Cancer Prevention.

Palanca A, Ampudia-Blasco FJ, Real JT. Palanca A, et al. Among authors: ampudia blasco fj. Nutrients. 2022 Jun 23;14(13):2593. doi: 10.3390/nu14132593. Nutrients. 2022. PMID: 35807774 Free PMC article. Review.

6

Effect of personality on blood glucose control in patients with type 1 diabetes.

Gu Hong WC, Ferri J, Ampudia-Blasco FJ, Martín-Brufau R, Peiró M, Benito E, Martinez-Hervas S, Sanz MJ, Real JT. Gu Hong WC, et al. Among authors: ampudia blasco fj. Endocrinol Diabetes Nutr (Engl Ed). 2022 Nov;69(9):677-685. doi: 10.1016/j.endien.2021.11.034. Endocrinol Diabetes Nutr (Engl Ed). 2022. PMID: 36470643

7

Two clinical cases of adjunctive use of a SGLT-2 inhibitor in type 1 diabetes.

Siegmund T, Ampudia-Blasco FJ, Schnell O. Siegmund T, et al. Diabetes Res Clin Pract. 2020 Apr;162:108131. doi: 10.1016/j.diabres.2020.108131. Epub 2020 Mar 29. Diabetes Res Clin Pract. 2020. PMID: 32234505

8

Which people with diabetes are treated with a disposable, half-unit insulin pen? A real-world, retrospective, database study in Spain.

Ampudia-Blasco FJ, Duque N, Artime E, Caveda E, Spaepen E, Díaz-Cerezo S, de Santos MR, Velasco DC, Bahíllo-Curieses MP. Ampudia-Blasco FJ, et al. Endocrinol Diabetes Metab. 2023 Nov;6(6):e451. doi: 10.1002/edm2.451. Epub 2023 Sep 15. Endocrinol Diabetes Metab. 2023. PMID: 37715339 Free PMC article.

9

Basal plus basal-bolus approach in type 2 diabetes.

Ampudia-Blasco FJ, Rossetti P, Ascaso JF. Ampudia-Blasco FJ, et al. Diabetes Technol Ther. 2011 Jun;13 Suppl 1:S75-83. doi: 10.1089/dia.2011.0001. Diabetes Technol Ther. 2011. PMID: 21668340 Review.

10

A decision support tool for appropriate glucose-lowering therapy in patients with type 2 diabetes.

Ampudia-Blasco FJ, Benhamou PY, Charpentier G, Consoli A, Diamant M, Gallwitz B, Khunti K, Mathieu C, Ridderstråle M, Seufert J, Tack C, Vilsbøll T, Phan TM, Stoevelaar H. Ampudia-Blasco FJ, et al. Diabetes Technol Ther. 2015 Mar;17(3):194-202. doi: 10.1089/dia.2014.0260. Epub 2014 Oct 27. Diabetes Technol Ther. 2015. PMID: 25347226 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

71 results

Search Page

Filters